The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients

Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the management of malignant and benign neoplasms. Detecting circulating DNA in cancer patients may help develop a DNA profile for early stage diagnosis in malignancies. The technical issues of obtaining, using, and analyzing CCFDNA from blood will be discussed.

• Publication year

  2013

• Venue

  International Journal of Molecular Sciences

• Publication date

  2013-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3390/ijms140918925PMID 24065096PMCID 3794814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic variants in fas signaling pathway genes and risk of gastric cancer

  2014cited by this paper
• Circulating plasma DNA and DNA integrity in breast cancer patients undergoing neoadjuvant chemotherapy.

  2013cited by this paper
• Characterization of cell-free circulating DNA in plasma in patients with prostate cancer

  2013cited by this paper
• Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients

  2013cited by this paper
• Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer

  2013cited by this paper
• Role of Tumor Necrosis Factor-α -308 G/A Promoter Polymorphism in Gastric Cancer

  2013cited by this paper
• Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study

  2013cited by this paper
• Microsatellite instability affecting the T17 repeats in intron 8 of HSP110, as well as five mononucleotide repeats in patients with colorectal carcinoma.

  2013cited by this paper
• Genetic instability of the tumor suppressor gene FHIT in normal human cells

  2013cited by this paper
• Circulating cell-free DNA in serum as a biomarker of colorectal cancer

  2013cited by this paper
• DNA methylation contributes to natural human variation

  2013cited by this paper
• Circulating tumor DNA to monitor metastatic breast cancer.

  2013cited by this paper
• Circulating tumor DNA to monitor metastatic breast cancer.

  2013cited by this paper
• Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.

  2013cited by this paper
• Circulating cell free DNA: Preanalytical considerations.

  2013cited by this paper
• A modified Phenol-chloroform extraction method for isolating circulating cell free DNA of tumor patients

  2013cited by this paper
• A Novel Approach for Characterizing Microsatellite Instability in Cancer Cells

  2013cited by this paper
• Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load.

  2013cited by this paper
• Analysis of circulating tumor DNA to monitor metastatic breast cancer.

  2013cited by this paper
• Monitor tumor burden with circulating tumor DNA

  2013cited by this paper
• Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks.

  2013cited by this paper
• Elevated level of cell-free plasma DNA is associated with advanced-stage breast cancer and metastasis

  2013cited by this paper
• Methylated tissue factor pathway inhibitor 2 (TFPI2) DNA in serum is a biomarker of metastatic melanoma.

  2013cited by this paper
• The balancing act of DNA repeat expansions.

  2013cited by this paper
• Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis

  2013cited by this paper
• Personalized therapy for breast cancer: a dream or a reality?

  2013cited by this paper
• Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR

  2013cited by this paper
• Novel Insights into Breast Cancer Genetic Variance through RNA Sequencing

  2013cited by this paper
• CST6 promoter methylation in circulating cell-free DNA of breast cancer patients.

  2013cited by this paper
• Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events.

  2013cited by this paper
• Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients.

  2013cited by this paper
• Integrative prediction of gene function and platinum-free survival from genomic and epigenetic features in ovarian cancer.

  2013cited by this paper
• Circulating biomarkers of CNS tumors: an update.

  2013cited by this paper
• Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients

  2013cited by this paper
• Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.

  2013cited by this paper
• Circulating tumor DNA to monitor metastatic breast cancer.

  2013cited by this paper
• No association between genetic variants in angiogenesis and inflammation pathway genes and breast cancer survival among Chinese women.

  2013cited by this paper
• Genetic Polymorphisms in DNA Repair Genes XRCC4 and XRCC5 and Aflatoxin B1–related Hepatocellular Carcinoma

  2013cited by this paper
• Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients.

  2013cited by this paper
• Genome-wide association study in breast cancer survivors reveals SNPs associated with gene expression of genes belonging to MHC class I and II.

  2013cited by this paper
• Similarities of molecular genetic changes in synchronous and metachronous colorectal cancers are limited and related to the cancers' proximities to each other.

  2013cited by this paper
• Plasma Cell-Free DNA in Paediatric Lymphomas

  2013cited by this paper
• Akonni TruTip® and Qiagen® Methods for Extraction of Fetal Circulating DNA - Evaluation by Real-Time and Digital PCR

  2013cited by this paper
• Comparison of KRAS Mutation Assessment in Tumor DNA and Circulating Free DNA in Plasma and Serum Samples

  2012cited by this paper
• Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers

  2012influential reference
• DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients

  2012cited by this paper
• The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

  2012cited by this paper
• Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

  2012cited by this paper
• Role of Circulating Free Alu DNA in Endometrial Cancer

  2012cited by this paper
• Circulating tumor cells and circulating tumor DNA.

  2012cited by this paper
• Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA

  2012cited by this paper
• Circulating Cell-Free DNA

  2012cited by this paper
• LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival

  2012cited by this paper
• Epigenetic markers of prostate cancer in plasma circulating DNA.

  2012cited by this paper
• Free Circulating Tumor DNA as a Diagnostic Marker for Breast Cancer

  2012cited by this paper
• Microsatellite Alterations and Cell-Free DNA Analysis: Could They Increase the Cytology Sensitivity in the Diagnosis of Malignant Pleural Effusion?

  2012cited by this paper
• Mutations in circulating mitochondrial DNA: Cassandra of oral cancer?

  2012cited by this paper
• Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer

  2012cited by this paper
• Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression

  2012cited by this paper
• Circulating DNA and next-generation sequencing.

  2012cited by this paper
• [Dynamic monitoring of plasma circulating DNA in patients with acute myeloid leukemia and its clinical significance].

  2012cited by this paper
• Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers

  2012cited by this paper
• Circulating DNA-Important Biomarker of Cancer

  2012influential reference
• Circulating cell-free nucleic acids: promising biomarkers of hepatocellular carcinoma.

  2012cited by this paper
• Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content

  2012cited by this paper
• Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA

  2012cited by this paper
• Measurement of Circulating Cell‐Free DNA in Relation to 18F‐Fluorocholine PET/CT Imaging in Chemotherapy‐Treated Advanced Prostate Cancer

  2012cited by this paper
• DNA Methylation in Peripheral Blood: A Potential Biomarker for Cancer Molecular Epidemiology

  2012cited by this paper
• Simultaneous Quantification of Mitochondrial DNA Damage and Copy Number in Circulating Blood: A Sensitive Approach to Systemic Oxidative Stress

  2012cited by this paper
• Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.

  2012cited by this paper
• Clinical Significance of Promoter Hypermethylation of ERβ and RARβ2 in Tumor and Serum DNA in Indian Breast Cancer Patients

  2012cited by this paper
• Circulating cell-free DNA: A promising marker of regional lymphonode metastasis in breast cancer patients

  2011cited by this paper
• Methylation patterns in cell‐free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients

  2011cited by this paper
• High Fragmentation Characterizes Tumour-Derived Circulating DNA

  2011cited by this paper
• Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids.

  2011cited by this paper
• Circulating free DNA and p53 antibodies in plasma of patients with ovarian epithelial cancers.

  2011cited by this paper
• Detection of HER2 amplification in circulating free DNA in patients with breast cancer

  2011cited by this paper
• Cell-free nucleic acids as biomarkers in cancer patients

  2011cited by this paper
• Circulating free DNA, p53 antibody and mutations of KRAS gene in endometrial cancer

  2010cited by this paper
• Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature.

  2010cited by this paper
• Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades.

  2010cited by this paper
• Genetic variation in CYP17A1 and pancreatic cancer in a population‐based case‐control study in the San Francisco Bay Area, California

  2010cited by this paper
• Differential methylation of cell‐free circulating DNA among patients with pancreatic cancer versus chronic pancreatitis

  2010cited by this paper
• Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer.

  2010cited by this paper
• Impact of the menstrual cycle on circulating cell-free DNA.

  2010cited by this paper
• Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis

  2010cited by this paper
• TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.

  2009cited by this paper
• Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome

  2009cited by this paper
• Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer.

  2009cited by this paper
• Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas

  2009cited by this paper
• Profile of the circulating DNA in apparently healthy individuals.

  2009cited by this paper
• Analysis of methylated circulating DNA in cancer patients' blood.

  2009cited by this paper
• Quantitative analysis of tumor-derived methylated RUNX3 sequences in the serum of gastric cancer patients.

  2009cited by this paper
• Szabad DNS-alapú vastagbéldaganat-szűrés perifériás vérből: a metilált szeptin-9 génmarker lehetőségei Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker

  2009cited by this paper
• Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas.

  2009cited by this paper
• CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.

  2009cited by this paper
• Quantification of circulating cell‐free DNA in the plasma of cancer patients during radiation therapy

  2009cited by this paper
• Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer

  2009cited by this paper
• A rapid direct fluorescent assay for cell-free DNA quantification in biological fluids

  2009cited by this paper
• Optimizing the yield and utility of circulating cell-free DNA from plasma and serum.

  2009cited by this paper

• The Role of Ultrasonography in Predicting Genetic Characteristics of Endometrial Cancers

  2025cites this paper
• MammaTrace -- a cell-free DNA methylation plasma only assay for minimal residual disease detection in breast cancer patients

  2025cites this paper
• Liquid biopsy as a potential tool for diagnosis and clinical monitoring of cutaneous and uveal melanoma

  2025cites this paper
• Cell-free DNA integrity and complement C4d as novel liquid biopsy biomarkers for paraneoplastic and non-paraneoplastic autoimmune encephalitis

  2025cites this paper
• Detection of Genomic Copy Number Variations in Ovarian Cancer in the Peripheral Blood System

  2025cites this paper
• Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value

  2024cites this paper
• Diagnosis of tuberculous lymphadenitis by molecular and immunological tools

  2024cites this paper
• Optimizing Accuracy and Efficiency in Analyzing Non-UMI Liquid Biopsy Datasets Using the Sentieon ctDNA Pipeline

  2024cites this paper
• Comparison of plasma and blood cell samples in metagenomic next-generation sequencing for identification of the causative pathogens of fever

  2024influential citation
• A comparative study on the detection of Mycobacterium leprae DNA in urine samples of leprosy patients using Rlep-PCR with other conventional samples

  2024cites this paper
• Circulating nucleosomes as potential biomarkers for cancer diagnosis and treatment monitoring.

  2024cites this paper
• Targeted Sequencing of Human Satellite 2 Repeat Sequences in Plasma cfDNA Reveals Potential Breast Cancer Biomarkers

  2024cites this paper
• Processing UMI Datasets at High Accuracy and Efficiency with the Sentieon ctDNA Analysis Pipeline

  2024cites this paper
• Diagnostic value of plasma and blood cells metagenomic next-generation sequencing in patients with sepsis.

  2023cites this paper
• False Positives in Brucellosis Serology: Wrong Bait and Wrong Pond?

  2023cites this paper
• Clinical evaluation of cell-free and cellular metagenomic next-generation sequencing of infected body fluids

  2023cites this paper
• Diagnosis of echinococcosis by detecting circulating cell-free DNA and miRNA

  2023cites this paper
• Monitoring plasma nucleosome concentrations to measure disease response and progression in dogs with hematopoietic malignancies

  2023cites this paper
• Hepatocellular carcinoma detection via targeted enzymatic methyl sequencing of plasma cell-free DNA

  2023cites this paper
• The Organization of Contemporary Biobanks for Translational Cancer Research

  2023cites this paper
• Clinical Evidence of Circulating Tumor DNA Application in Aggressive Breast Cancer

  2023cites this paper
• Ω-shaped fiber optic LSPR biosensor based on mismatched hybridization chain reaction and gold nanoparticles for detection of circulating cell-free DNA.

  2023cites this paper
• OvaPrint—A Cell-free DNA Methylation Liquid Biopsy for the Risk Assessment of High-grade Serous Ovarian Cancer

  2023cites this paper
• Clinical utility of liquid biopsy in canine oral malignant melanoma using cell-free DNA

  2023cites this paper
• Microbial cell-free DNA detection: Minimally invasive diagnosis of infectious diseases.

  2023cites this paper
• Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature.

  2023cites this paper
• The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management

  2023cites this paper
• Cell‐free DNA integrity correlates with lymph node metastasis and predicts short‐term postoperative recurrence in patients with proximal gastric carcinoma after curative gastrectomy

  2023cites this paper
• Time-series prediction and detection of potential pathogens in bloodstream infection using mcfDNA sequencing

  2023cites this paper
• Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection

  2023cites this paper
• Evaluation of Mycobacterium tuberculosis derived cell-free DNA using pleural fluid and paired plasma samples for the diagnosis of pleural tuberculosis.

  2023cites this paper
• Bioplatforms in liquid biopsy: advances in the techniques for isolation, characterization and clinical applications

  2022cites this paper
• Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer

  2022cites this paper
• Liquid Biopsies in Colorectal Liver Metastases: Towards the Era of Precision Oncologic Surgery

  2022cites this paper
• Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA Analysis

  2022cites this paper
• Liquid Biopsy: A Distinctive Approach to the Diagnosis and Prognosis of Cancer

  2022cites this paper
• The Influence of Proteins on Fate and Biological Role of Circulating DNA

  2022cites this paper
• Variability of endogenous deoxyribonuclease activity and its pathophysiological consequences.

  2022cites this paper
• Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer

  2022cites this paper
• Cell-free DNA methylation as a potential biomarker in brain disorders.

  2022cites this paper
• Comparative Evaluation of Diagnostic Performance of Circulating free DNA by Conventional vs. Real Time PCR in Gallbladder Cancer

  2022cites this paper
• Epigenetics and Testicular Cancer: Bridging the Gap Between Fundamental Biology and Patient Care

  2022cites this paper
• Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study

  2022cites this paper
• Liquid biopsy in bladder tumors

  2022cites this paper
• Evaluation of circulating cell-free nucleic acids in health workers occupationally exposed to ionizing radiation

  2022cites this paper
• Cell-free DNA diagnostics in transplantation utilizing next generation sequencing.

  2021cites this paper
• Fragmentation Analysis of Plasma DNA Reveals Its Prognostic Value in Gastric Cancer.

  2021cites this paper
• Levels of Circulating DNA in Blood Serum and DNA Damage in Leukocytes of Healthy Donors of Different Genders and Ages

  2021cites this paper
• Clinical correlates of circulating cell-free DNA tumor fraction

  2021cites this paper
• A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies

  2021cites this paper
• Prognostic biomarkers for cholangiocarcinoma (CCA): state of the art

  2021cites this paper
• Exploring miRNA Signature and Other Potential Biomarkers for Oligometastatic Prostate Cancer Characterization: The Biological Challenge behind Clinical Practice. A Narrative Review

  2021cites this paper
• Stance of MRD in Non-Hodgkin’s Lymphoma and its upsurge in the novel era of cell-free DNA

  2021cites this paper
• Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature

  2021cites this paper
• A novel proteomics approach to epigenetic profiling of circulating nucleosomes

  2021cites this paper
• Early cancer detection from genome-wide cell-free DNA fragmentation via shuffled frog leaping algorithm and support vector machine

  2021cites this paper
• Colorectal Cancer Screening: Theory and Practical Application

  2021cites this paper
• Liquid biopsy: the current state of the issue

  2021cites this paper
• Detecting Endometrial Cancer by Blood Spectroscopy: A Diagnostic Cross-Sectional Study

  2020cites this paper
• Preanalytical variables that affect the outcome of cell-free DNA measurements

  2020cites this paper
• Circulating miR34a levels as a potential biomarker in the follow-up of Ewing sarcoma

  2020cites this paper
• Mutational profile in circulating tumor DNA in a patient affected by low-risk endometrial cancer: predictable tool of relapse?

  2020cites this paper
• Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing

  2020cites this paper
• A Dual Antibody-modified Nanochannel Biosensor for Capture and Identification of Exosomes

  2020cites this paper
• Origin of circulating free DNA in patients with lung cancer

  2020cites this paper
• Cell-free circulating epimarks in cancer monitoring.

  2020cites this paper
• A Retrospective Review of 300 Case Reports, Quality of Life and Correlation with Biomarkers Related To Tumor Burden, in Advanced Cancer

  2020cites this paper
• Investigating the relationship between ccfDNA concentration, its integrity, and some individual factors in an Iranian population.

  2020cites this paper
• Serbest Mitokondriyal Dna nın Sistemik Dolaşımdaki Rolü Ve Hastalıkların Patogenezine Etkisi

  2020cites this paper
• Emerging biomarkers in chronic lung allograft dysfunction

  2020cites this paper
• Liquid biopsies in urological cancers: what we need to know before starting using them

  2020cites this paper
• The potential of circulating tumor DNA to use as a molecular marker to screen and diagnose hepatocellular carcinoma: A systematic review

  2020cites this paper
• Genotype-specific differences in circulating tumor DNA levels in advanced NSCLC.

  2020cites this paper
• Options of Colorectal Cancer Screening: An Overview

  2020cites this paper
• Extracellular genetic materials and their application in clinical practice.

  2020cites this paper
• Rapid and sensitive identification of pleural and peritoneal infections by droplet digital PCR

  2020cites this paper
• Detection of circulating tumor DNA by digital droplet PCR in resectable lung cancer as a predictive tool for recurrence.

  2020cites this paper
• [Liquid biopsy-a possible key player in immuno-oncology].

  2020cites this paper
• Liquid biopsy for esophageal cancer: Is detection of circulating cell‐free DNA as a biomarker feasible?

  2020cites this paper
• Application of Circulating Cell‐free DNA for Personalized Cancer Therapy

  2020cites this paper
• Utility of circulating cell-free Mycobacterium tuberculosis DNA for the improved diagnosis of abdominal tuberculosis

  2020cites this paper
• Liquid Biopsy in Prostate Cancer Diagnosis and Prognosis: A Narrative Review

  2020cites this paper
• A comparison of four commercial kits used for isolating circulating cell-free DNA: QuickGeneMINI8L (Kurabo), Maxwell RSC cfDNA Plasma Kit (Promega), cfKapture 21 Kit (MagBio), and QIAamp MinElute ccfDNA Kit (Qiagen)

  2020cites this paper
• Circulating nucleic acids in the plasma and serum as potential biomarkers in neurological disorders

  2020influential citation
• „Liquid biopsy“ als Schlüsselfigur in der Immunonkologie

  2020cites this paper
• Evaluation of circulating cell-free nuclear and mitochondrial DNA levels in Syrian patients with breast tumor

  2020cites this paper
• A microfluidic chip-based assay outperforms common methods for quantification of cell-free DNA and RNA

  2019cites this paper
• University of Groningen RAS and BRAF mutations in cell-free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue-tested RAS wild-type advanced colorectal cancer

  2019cites this paper
• Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next-Generation Sequencing in Detecting Actionable Driver Mutations in Anti-EGFR Naive Metastatic Colorectal Cancer.

  2019cites this paper
• Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer

  2019cites this paper
• Discrimination of the V600E mutation in BRAF by rolling-circle-amplification Förster resonance energy transfer (RCA-FRET).

  2019cites this paper
• RAS and BRAF mutations in cell‐free DNA are predictive for outcome of cetuximab monotherapy in patients with tissue‐tested RAS wild‐type advanced colorectal cancer

  2019cites this paper
• Liquid Biopsy in Oligometastatic Prostate Cancer—A Biologist's Point of View

  2019cites this paper
• A Study of Pre-Analytical Variables and Optimization of Extraction Method for Circulating Tumor DNA Measurements by Digital Droplet PCR

  2019cites this paper
• Cell-free DNA as Diagnostic Markers

  2019influential citation
• The Rediscovery of the DNA Molecule in Liquid Biopsies in Cancer.

  2019cites this paper
• Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study

  2019cites this paper
• Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.

  2019cites this paper
• On-chip isolation and enrichment of circulating cell-free DNA using microfluidic device.

  2019cites this paper
• Clinical validity of saliva and novel technology for cancer detection.

  2019cites this paper